High expression of EZH2 is observed in lung cancer and relates to poor prognosis of lung cancer patients; both knockdown of EZH2 and application of EZH2 suppressors are capable of suppressing cell viability and cell line migrations of lung cancer and enhancing apoptosis and chemotherapy sensitivity [16]. Here, EZH2 is linked to lung carcinoma.